InflaRx (IFRX) director Mark Kubler reports 960,015 shares and multiple options
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
InflaRx N.V. director Mark Kubler filed an initial ownership report showing direct holdings of 960,015 Ordinary Shares of IFRX. He also reports several stock option awards over Ordinary Shares, including options over 7,308 shares at an exercise price of 0.0131 expiring on December 31, 2050. Most options described are fully vested and exercisable, while a grant made on January 6, 2026 for 30,000 underlying shares will vest in four equal installments of 7,500 shares on each quarterly anniversary of that grant date, subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
10 transactions reported
Mixed
10 txns
Insider
Kubler Mark
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 7,308 shares (Direct);
Ordinary Shares — 960,015 shares (Direct)
Footnotes (1)
- This option was granted on July 21, 2016 and is fully vested and exercisable as of the date hereof. This option was granted on December 13, 2017 and is fully vested and exercisable as of the date hereof. This option was granted on January 4, 2021 and is fully vested and exercisable as of the date hereof. This option was granted on July 2, 2021 and is fully vested and exercisable as of the date hereof. This option was granted on January 12, 2022 and is fully vested and exercisable as of the date hereof. This option was granted on January 24, 2023 and is fully vested and exercisable as of the date hereof. This option was granted on January 5, 2024 and is fully vested and exercisable as of the date hereof. This option was granted on January 3, 2025 and is fully vested and exercisable as of the date hereof. This option was granted on January 6, 2026 and will vest and become exercisable in four equal installments of 7,500 shares on each quarterly anniversary of such grant date, subject to continued service through such dates.
